The α7 nicotinic acetylcholine receptor agonist, A-582941, regulates GSK3β and tau phosphorylation:: Potential for disease modification in Alzheimer's disease

被引：0
|
作者：
Nikkel, A. L. [1 ]
Markosyan, S. [1 ]
Martino, B. [1 ]
Gubbins, E. [1 ]
Li, J. [1 ]
Han, E. K. [1 ]
Luo, Y. [1 ]
Hu, M. [1 ]
Puttfarcken, P. [1 ]
Decker, M. [1 ]
Gopalakrishnan, M. [1 ]
Bitner, R. S. [1 ]
机构：
[1] Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA
来源：
BIOCHEMICAL PHARMACOLOGY | 2007年 / 74卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：SMA28 / SMA29
页数：2
相关论文
共 50 条
  • [21] Role of A β and the α 7 nicotinic acetylcholine receptor in regulating synaptic plasticity in Alzheimer's disease
    David H. Small
    Lisa R. Fodero
    Dusan Losic
    Cindy Chu
    Marie-Isabel Aguilar
    Lisandra L. Martin
    Mary Chebib
    Letters in Peptide Science, 2003, 10 : 401 - 404
  • [22] Increased α7 nicotinic acetylcholine receptor protein levels in Alzheimer's disease patients
    Chu, LW
    Ma, ES
    Lam, KK
    Chan, MF
    Lee, DH
    NEUROBIOLOGY OF AGING, 2004, 25 : S34 - S34
  • [23] α7 nicotinic acetylcholine receptor agonist attenuates the cerebral injury in a rat model of cardiopulmonary bypass by activating the Akt/GSK3β pathway
    Sun, Yingjie
    Song, Dandan
    Wang, Mei
    Chen, Keyan
    Zhang, Tiezheng
    MOLECULAR MEDICINE REPORTS, 2017, 16 (06) : 7979 - 7986
  • [24] Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies:: Increased α7 immunoreactivity of astrocytes in Alzheimer's disease
    Teaktong, T
    Graham, A
    Court, J
    Johnson, M
    Hall, R
    Perry, E
    Perry, R
    Jaros, E
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S491 - S491
  • [25] α4 but not α3 and α7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer' s disease
    Martin-Ruiz, CM
    Court, JA
    Molnar, E
    Lee, M
    Gotti, C
    Mamalaki, A
    Tsouloufis, T
    Tzartos, S
    Ballard, C
    Perry, RH
    Perry, EK
    JOURNAL OF NEUROCHEMISTRY, 1999, 73 (04) : 1635 - 1640
  • [26] Genetic Variation in the α7 Nicotinic Acetylcholine Receptor is Associated with Delusional Symptoms in Alzheimer's Disease
    Carson, Robyn
    Craig, David
    Hart, Dominic
    Todd, Stephen
    McCuinness, Bernadette
    Johnston, Janet A.
    O'Neill, Francis A.
    Ritchie, Craig W.
    Passmore, A. Peter
    NEUROMOLECULAR MEDICINE, 2008, 10 (04) : 377 - 384
  • [27] Virtual screening for alpha7 nicotinic acetylcholine receptor for treatment of Alzheimer's disease
    Chen, Shi-Gao
    Gu, Ruo-Xu
    Dai, Hao
    Wei, Dong-Qing
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2013, 39 : 98 - 107
  • [28] Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease
    Parri, H. Rheinallt
    Hernandez, Caterina M.
    Dineley, Kelly T.
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (08) : 931 - 942
  • [29] Increased alpha 7 nicotinic acetylcholine receptor protein levels in Alzheimer's disease patients
    Chu, LW
    Ma, ESK
    Lam, KKY
    Chan, MF
    Lee, DHS
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2005, 19 (2-3) : 106 - 112
  • [30] Decreased α7 nicotinic acetylcholine receptor protein levels in sporadic Alzheimer's disease hippocampus
    Lee, DHS
    D'Andrea, MR
    Plata-Salaman, CR
    Wang, HY
    ALZHEIMERS REPORTS, 2000, 3 (04): : 217 - 220
12345